← All stocks

RELMADA THERAPEUTICS, INC.

RLMD Net buying
CIK 0001553643 #3112 in the set updated 17 Sep 2026
Bought (120 mo)
$6.53M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$13.17M
$0.00 on a plan · $10.41M straight out of an exercise
Sold at will
$2.75M
35 of 85 sales
Net
−$6.63M
+$3.78M against sales at will

By person

7 insiders · 147 transactions
Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Kelly Paul Edward
COO
$735.56K (13)
$7.48M (17) scheduled
−$6.74M
502,295
$2.06M
CASAMENTO CHARLES J
Director
$33.28K (1)
$2.14M (26)
−$2.11M
21,484
$88.08K
Shenouda Maged
Chief Financial Officer
$2.39M (14)
$1.26M (18)
+$1.13M
1,000,000
$4.10M
+79,900%
Ence Chuck
CA and CO
$553.45K (5)
+$553.45K
403,931
$1.66M
TRAVERSA SERGIO
Chief Executive Officer
$2.79M (17)
$2.29M (24) scheduled
+$506.06K
1,500,000
$6.15M
+4,961%
O'Gorman Cedric
Chief Medical Officer
$31.80K (1)
+$31.80K
10,121
$41.50K
+8,264%
SCHMIDT ERIC THOMAS
Director
100,000
$410.00K
+81.8%

No percentages here. This company's share count has moved by a factor of 3.5 over the window, from 30,174,202 to 106,669,846 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.

Nothing of that kind in this period.

What was left out

Form 4 filings counted 162
Amendments (4/A) skipped 3
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 50
Sales at will 35
Transactions with no price 0
Shares from compensation/vesting 769,730
Sales filed before the plan box existed 35
History held since 6 Oct 2017